For investors seeking momentum, iShares Russell 2000 ETF (IWM - Free Report) is probably on radar. The fund just hit a 52-week high and is up 117% from its 52-week low of $95.69 per share.
But are more gains in store for this ETF? Let’s take a quick look at the fund and the near-term outlook on it to get a better idea on where it might be headed.
IWM in Focus
This fund targets the small-cap segment of the broad U.S. equity market with key holdings in healthcare, industrials, financials, information technology and consumer discretionary. It charges 19 basis points in annual fees (see: all the Small-Cap Blend ETFs here).
Why the Move?
The small-cap corner of the broad U.S. stock market has been an area to watch lately given its outperformance in the first week of 2021. COVID-19 vaccine rollout, and hopes of a bigger fiscal package and infrastructure spending under a Democratic-led U.S. Congress are propelling the small-cap indices to new highs. As small-cap companies are closely tied to the U.S. economy, these are poised to outperform when the economy improves.
More Gains Ahead?
Currently, IWM has a Zacks ETF Rank #3 (Hold) with a Medium risk outlook. Therefore, it is hard to get a handle on its future returns one way or the other. However, many of the segments that make up this ETF have a strong Zacks Industry Rank. So, there is definitely some promise for those who want to ride this surging ETF a little further.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
For investors seeking momentum, iShares Russell 2000 ETF (IWM - Free Report) is probably on radar. The fund just hit a 52-week high and is up 117% from its 52-week low of $95.69 per share.
But are more gains in store for this ETF? Let’s take a quick look at the fund and the near-term outlook on it to get a better idea on where it might be headed.
IWM in Focus
This fund targets the small-cap segment of the broad U.S. equity market with key holdings in healthcare, industrials, financials, information technology and consumer discretionary. It charges 19 basis points in annual fees (see: all the Small-Cap Blend ETFs here).
Why the Move?
The small-cap corner of the broad U.S. stock market has been an area to watch lately given its outperformance in the first week of 2021. COVID-19 vaccine rollout, and hopes of a bigger fiscal package and infrastructure spending under a Democratic-led U.S. Congress are propelling the small-cap indices to new highs. As small-cap companies are closely tied to the U.S. economy, these are poised to outperform when the economy improves.
More Gains Ahead?
Currently, IWM has a Zacks ETF Rank #3 (Hold) with a Medium risk outlook. Therefore, it is hard to get a handle on its future returns one way or the other. However, many of the segments that make up this ETF have a strong Zacks Industry Rank. So, there is definitely some promise for those who want to ride this surging ETF a little further.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on IWM - FREE